Skip to main content
SpringerLink
Log in

Cost effectiveness of hepatitis A prophylaxis depends on risk

  • Drug Economics and quality of Life
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. van Doorslaer D, Tormans G, van Damme P. Cost-effectiveness analysis of vaccination against hepatitis A in travellers. J Med Virol 1994 Dec; 44: 463–9

    Article  PubMed  Google Scholar 

  2. Severo CA, Fagnani F, Lafuma A. Cost effectiveness of hepatitis A prevention in France. PharmacoEconomics 1995 Sep; 8: 46–61

    Article  PubMed  CAS  Google Scholar 

  3. van Doorslaer D, Tormans G, van Damme P, et al. Cost effectiveness of alternative hepatitis A immunisation strategies. PharmacoEconomics 1995 Sep; 8: 5–8

    Article  PubMed  Google Scholar 

  4. Vaccination against hepatitis A. New Ethicals 1992 May; 29: 33–35

    Google Scholar 

  5. Jefferson TO, Behrens RH, Demicheli V Should British soldiers be vaccinated against hepatitis A? An economic analysis. Vaccine 1994 Nov; 12: 1379–83

    Article  PubMed  CAS  Google Scholar 

  6. Steffen R, Kane MA, Shapiro CN, et al. Epidemiology and prevention of hepatitis A in travelers. JAMA 1994 Sep 21; 272: 885–9

    Article  PubMed  CAS  Google Scholar 

  7. Steffen R. Risk of hepatitis in travellers. Vaccine 1992; 10 Suppl. 1: S69–S72

    Article  PubMed  Google Scholar 

  8. Kendall BJ, Cooksley WGE. Prophylactic treatment regimens for the prevention of hepatitis A. Current concepts. Drugs 1991 Jun; 41: 883–8

    CAS  Google Scholar 

  9. Tormans G, van Damme P, van Doorslaer D. Cost-effectiveness analysis of hepatitis A prevention in travellers. Vaccine 1992; 10 Suppl. 1: S88–S92

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cost effectiveness of hepatitis A prophylaxis depends on risk. Drugs Ther. Perspect 6, 12–14 (1995). https://doi.org/10.2165/00042310-199506100-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199506100-00005

Search

Navigation